Pricing Log in Create free account

Olema Pharmaceuticals, Inc. (OLMA) vs Sagimet Biosciences Inc. (SGMT)

Olema Pharmaceuticals, Inc. and Sagimet Biosciences Inc. are both Biotechnology companies. Olema Pharmaceuticals, Inc. and Sagimet Biosciences Inc. are of similar size ($601.1M and $574.7M). Across the 10 metrics below, Sagimet Biosciences Inc. leads on 7 and Olema Pharmaceuticals, Inc. on 3.

Valuation

Metric OLMA SGMT Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 1.60 1.66 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield (32.22%) (15.96%) (33.15%)
Free cash flow yield (24.00%) (9.79%) (25.50%)

Profitability

Metric OLMA SGMT Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (52.74%) (24.37%) (56.36%)
Return on assets (47.10%) (23.49%) (48.04%)
Return on invested capital 0.00% (205.24%) 0.00%

Growth

Metric OLMA SGMT Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 15.00% (8.97%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric OLMA SGMT Biotechnology median
Debt to equity 0.01 0.00 0.00
Current ratio 8.86 45.02 4.72
Net debt to EBITDA 2.82 1.98 0.96

Dividend

Metric OLMA SGMT Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric OLMA SGMT Biotechnology median
Market cap 601.10m 574.68m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack